Maven Securities LTD Natera, Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$85.28 - $112.6 $170,560 - $225,200	2,000 New	2,000 $216,000
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $1.85 Million - $2.33 Million	-18,461 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $144,047 - $200,411	-1,674 Reduced 8.31%	18,461 $2.11 Million
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $694,897 - $944,762	-7,597 Reduced 27.39%	20,135 $2.01 Million
Q4 2020 Feb 12, 2021	BUY	$66.66 - $111.74 $1.85 Million - $3.1 Million	27,732 New	27,732 $2.76 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.